1. Approved and emerging treatments of malignant pleural mesothelioma in elderly patients. (2nd December 2019) Authors: Ceresoli, Giovanni Luca; Rossi, Antonio Journal: Expert review of respiratory medicine Issue: Volume 13:Number 12(2019) Page Start: 1179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients. (February 2020) Authors: Reale, Maria Lucia; Chiari, Rita; Tiseo, Marcello; Vitiello, Fabiana; Barbieri, Fausto; Cortinovis, Diego; Ceresoli, Giovanni Luca; Finocchiaro, Giovanna; Romano, Gianpiero Diego; Piovano, Pier Luigi; Del Conte, Alessandro; Borra, Gloria; Verderame, Francesco; Scotti, Vieri; Nonnis, Daniela; Gale... Journal: Lung cancer Issue: Volume 140(2020) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. (August 2019) Authors: Capelletto, Enrica; Migliorino, Maria Rita; Morabito, Alessandro; Chiari, Rita; Grossi, Francesco; Tiseo, Marcello; Costanzo, Francesco Di; Delmonte, Angelo; Romano, Gianpiero; Galetta, Domenico; Scotti, Vieri; Gregorc, Vanesa; Pisconti, Salvatore; Ceresoli, Giovanni Luca; Del Conte, Alessandro; ... Journal: Lung cancer Issue: Volume 134(2019) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 10 (October 2021) Authors: Pinto, Carmine; Zucali, Paolo Andrea; Pagano, Maria; Grosso, Federica; Pasello, Giulia; Garassino, Marina Chiara; Tiseo, Marcello; Soto Parra, Hector; Grossi, Francesco; Cappuzzo, Federico; de Marinis, Filippo; Pedrazzoli, Paolo; Bonomi, Maria; Gianoncelli, Letizia; Perrino, Matteo; Santoro, Arma... Journal: Lancet oncology Issue: Volume 22:Issue 10(2021) Page Start: 1438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune checkpoint inhibitors in malignant pleural mesothelioma. Issue 5 (May 2017) Authors: Ceresoli, Giovanni Luca; Mantovani, Alberto Journal: Lancet oncology Issue: Volume 18:Issue 5(2017:May) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges. Issue 7 (2nd July 2016) Authors: Ceresoli, Giovanni Luca; Bonomi, Maria; Sauta, Maria Grazia Journal: Expert review of anticancer therapy Issue: Volume 16:Issue 7(2016) Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immune checkpoint inhibitors in mesothelioma: a turning point. Issue 10272 (30th January 2021) Authors: Ceresoli, Giovanni Luca; Pasello, Giulia Journal: Lancet Issue: Volume 397:Issue 10272(2021) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?. (July 2020) Authors: Di Noia, Vincenzo; D'Aveni, Alessandro; Squadroni, Michela; Beretta, Giordano Domenico; Ceresoli, Giovanni Luca Journal: Lung cancer Issue: Volume 145(2020) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences. (August 2017) Authors: Calabrò, Luana; Ceresoli, Giovanni Luca; D'Incecco, Armida; Scherpereel, Arnaud; Aerts, Joachim; Maio, Michele Journal: Cytokine & growth factor reviews Issue: Volume 36(2017) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program. (February 2020) Authors: Baldini, Editta; Lunghi, Alice; Cortesi, Enrico; Turci, Daniele; Signorelli, Diego; Stati, Valeria; Melotti, Barbara; Ricciuti, Biagio; Frassoldati, Antonio; Romano, Giampiero; Ceresoli, Giovanni Luca; Illiano, Alfonso; Verderame, Francesco; Fasola, Gianpiero; Ricevuto, Enrico; Marchetti, Paolo; ... Journal: Lung cancer Issue: Volume 140(2020) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗